Prosecution Insights
Last updated: April 19, 2026

Vektor Pharma Tf GmbH

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19307513 Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases GOTFREDSON, GAREN 1619 Final Rejection Aug 22, 2025

Managing Vektor Pharma Tf GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month